Tango Therapeutics, Inc. (TNGX) Operating income 2020–2025
Tango Therapeutics, Inc. (TNGX) annual operating income history from SEC filings — each fiscal year as reported.
-$111.3MFY2025 · since FY2020: -$52.2M → -$111.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$111.3M | +23.6% |
| FY2024 | -$145.6M | -27.5% |
| FY2023 | -$114.2M | -2.8% |
| FY2022 | -$111.1M | -90.9% |
| FY2021 | -$58.2M | -11.5% |
| FY2020 | -$52.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice